pregnancy and major cause of maternal-child mortality. The aim of this study was undertaken to perform cross-sectional research to evaluation agreement and a correlation between an IFN-γ releasing assay for detected latent Tb infection and anti-rubella antibodies tests in pregnant women with recurrent miscarriages.
INTRODUCTION
Miscarriage or abortion are among the most serious complications during pregnancy, with about 15% of all pregnancies ending with an abortion, and 25% of women who become pregnant will experience at least one abortion. Abortion was mostly known as the loss of two, three or more pregnancies, respectively [1] . The causes of pregnancy loss and miscarriage are diverse and controversial; the most common causes of recurrent miscarriages are genetics, hormonal, anatomic, immunologic, infectious and environmental factors [2, 3] . The role of infection in recurrent miscarriage is not yet clear, while associated with loss of late pregnancy, premature birth and premature rupture of membranes [4] . Rubella virus, more commonly known as rubella or three days, is spread through an infection that caused a mild infectious rash in children and young children [1, 5] . in the beginning trimester, the infections can lead to spontaneous abortion or congenital abnormalities.
Symptoms of measles are the most common and include mild fever, especially in childhood with a clear rash involving the entire body of the child and the possibility of recovery is possible, but urges infection occurs during the first months of gestation leading to fetal death, miscarriage, stillbirth or infants with a pattern of birth defects, known as congenital rubellasyndrome (CRS) [1, 3, 6, 7] . Iraq is one of the countries with a global burden of 25% in 2014, so TB is one of the most important priorities of the World Health Organization among 7 of the countries of the territory with a high burden of TB and accounts for 3% of the total number of cases. Which were estimated approximately 20 000 TB infected persons in Iraq and which were estimated deaths caused by TB was a greater extent of 4000 per annum [8] . Women which were at high risk of tuberculosis throughout the course pregnancy, usually assuming that associated immune changes with pregnancy represent a set of circumstances that makes it possible for TB infection or reactivation in the development of a pregnancy, a whole change in the immune-related have been perceived [9, 10] . The TB infection make greater mortality during pregnancy and postpartum while be observed that pregnant women with the pulmonary or extrapulmonary TB, as well own increased put on the line of complications including antenatal hospitalization includedmiscarriages [11] .The prevalence of Latent Tuberculosis infections (LTBI) in seropositive anti-rubella virus antibodies pregnant women who have been giving a preceding review [12, 13] .The confirmatory diagnosis of TB was connecting with based on culture confirmation and clinical or radiological signs compatible with active TB signs [10] .Investigation latent tuberculosis infections should be identified pregnancy at of great vertical extent risk of developing active disease throughout pregnancy that would profit gained from prophylactic therapy [12, 14] .IFN gamma releasing test which were considered as a useful alternative, to the tuberculin skin test, the advantage of IGRAs test which wasn't cross-react with BCG or environmental bacteria; but have disadvantagesare costly, need blood collection, proper processing, and lab substructure, and have not been widely validatedamong pregnant women [15, 16] . Women have been at raised risk of tuberculosis during pregnancy, and it was usually presupposed that immunological changes related to pregnancy present an opportunity for TB infections or reactivation [13, 15, 17] . In the early stages of pregnancy, a full range of changes in immunity are associated with identified. For these reasons, the American College of Obstetricians and Gynecologists and the Center for Disease Control and Prevention recommend screening all pregnant women at risk of tuberculosis at the start of prenatal care [15] . Pregnant women with pulmonary or non-lung tuberculosis, without lymphadenitis, may also have an increased risk of 
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complications such as prenatal hospitalization and the risk of miscarriage [17] . Presentlatent tuberculosis defections tools, the newer interferonIFN-γ release assays (IGRAs) insufficiently to differentiate latent tuberculosis from type active tuberculosis [18] .INF--γ release assays estimatedT cell responses to antigens (Ags) transcription from the region of difference-1, a region on the Mycobacterium Tuberculosis genome specific for Mycobacterium tuberculosis and not present in a Bacilli Calmette-Guérinand (BCG) most of the othermycobacteria [13, 15, 18] .
This study was undertaken to perform the cross-sectional research to an approximate calculation agreement and the correlation between an INF--γ release assays for detecting latent tuberculosis infections and antirubella antibodies tests in pregnant women with recurrent miscarriages.
MATERIALS AND METHODS
Study was carried out between 1 March 2018 Until 1 July 2019.Study groups: A total of 75 pregnant women living in TB-affected areas were in direct or indirect contact with an infected person from their families or relatives and had a history of recurrent miscarriage in the first months of pregnancy, their ages ranged from (18-41) years.
Two types of blood samples were drawn and prepared according to the type of analysis, and 10 mL of blood was withdrawn for each woman in both groups, which divided into two parts 5 ml put in a heparinized tubes anticoagulant for Interferon Gamma Release Assay test and 5 ml in a container without anticoagulant blood the samples which screened of Foresight Anti-Rubella(IgG, IgM) antibodiestype with the blood samples were obtained by vein puncture under aseptic condition, then collected in a dry clean plain tube without anticoagulant. Each tube was labeled with a code number, then the whole coagulated blood sample was centrifuged for 5 minutes at 2500 rpm and then 2 ml of serum was isolated and frozen at (-20°C ) until performing the tests Estimation the anti-Rubella (IgG,IgM) level in both study groups and the control groups.
Detection ofForesight Rubella IgG, IgM antibodies
The Rubella IgG, IgM EIA Test Kit ELISA (ACON Laboratories, Inc.) which are an enzyme immunoassay assay for the specific and quantitative recognition of IgG, IgM antibodies in the human serum or plasma. Its purpose is to aid in the diagnosis of possible Rubella infection. Rubella (IgG, IgM) EIA Test Kit is a solidphase enzyme immunoassay based on indirect principle for qualitative, quantitative detection of (IgG, IgM) antibodies to Rubella in human sera or plasma [19] .
Detection of IFN -gamma releasingAssay
The IFN-gamma release test were achieved according to the manufacturer's directions (ELISA) kit 
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manufacturer's protocol. The interferon-gamma assay test was defined as greater than or equal to 0.35 IU / ml after calculating the Nile and mitogen control results. The gamma-release assay test for negative viruses was defined as less than 0.35 IU / ml, which was after calculating the Nil and metogen control results [20] .
Statistical analysis:
These were used to accept or reject the statistical hypotheses. They included the following: Chi-square (χ 2 ), Student test (t-test).
RESULTS
Table (1) showed the studied group as divided into age group according to recurrent miscarriage. It showed that the age group (25-29) years was highly frequent in both groups (study and control), (30); (40%), (10), (33.3%) respectively, and not significant p>0.05. Table ( 2) showed the studied group as divided into age group according to number of abortions (two and three) inrecurrent miscarriage, and the result showed that the age group (25-29) was highly frequent in both groups( two and three) and control: (14) ;(31.1%),(16);(53.3%),(10);(33.3%) respectively, and not significant p> 0.05. Relationship of prevalence Anti Rubella (IgG,IgM) positive and number of recurrent miscarriage in study and control groups. Table ( 3)summarizes the Anti-Rubella IgG, IgM (positive) according to recurrent miscarriage, and the result showed that the number and percentage of Rubella IgG, IgM positive was (36)(48%);(22)(73.3%), (4)(5.3%);
(0)(0.0)in both groups(study and control) respectively, and significantP value> 0.05. 
Table (3): Relationship of prevalence Anti-rubella virus antibody(IgG

Relationship between Quantiferon IFN-γ release test and age group
Investigations on the Quantiferon test in different study group and control group according age groups showed that out of recurrent miscarriage pregnant women have positive result 4 (5.33) ;Which details the results in the table (4). 
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Comparison of results of Quantiferon assay and Anti-rubella virus antibody (IgG, IgM)
The table (5) shows comparison the results of two tests of Quantiferon release IFN-γ assay and Anti-rubella virus antibody (IgG, IgM) that hadsignificantrelationship P= 0.0443. 
DISCUSSION
Frequent miscarriage was one of the to the greatest extent health problems in developing countries. For several reasons, infectious diseases, especially rubella, are at risk of pregnancy in the first months.
Tuberculosis, especially in infected areas, is a complex health problem in Iraq, in particular, because of the scourge of war, while the economic deterioration over the past decades has been accompanied by the collapse of the public health infrastructure. This study was the first of its kind in the prevalence of recurrent miscarriage in women and linked to the cause of rubella virus infection and the potential role of tuberculosis or Latent Tuberculosis infections (LTBI) in women living in areas. Which are distributed in many areas in the Al-Diwaniyah, which is one of the cities that lack many of the infrastructure related to the addition of public health and the social situation of people, which dominated by poverty and ignorance. We have borne the expensive research cost of conducting tests to detect latent TB problems and, we have had difficulty collecting the sample from women because of social customs. There are many studies on the causes of abortion in pregnant women in Iraq and in the multiple stages of pregnancy [21, 22] . There is no special study on Tuberculosis in pregnant women because of the non-classification of TB cases but taking the total as a general infection. This is due to several reasons, such as social reality, ignorance and misunderstanding by patients and their families, and fear of going to the hospital and specialized centers to show their condition until it is too late and the progress of the disease [23, 24] . The study, conducted by us, sought to estimate the compatibility and relationship between gamma-release IFN for latent tuberculosis infection and rubella antibody testing (IgG, IgM) in pregnant women with a history of recurrent pregnancy loss.
Table (1) shows that the age group (25) (26) (27) (28) (29) is the category that showed the most cases of repeated miscarriage. This age group is very important in terms of high fertility of women in this age group compared to other age groups, the result is particularly worrisome which seem clear in the table (2) recurrent miscarriage with (Three abortions) age group (25) (26) (27) (28) (29) 53.3%, this finding is closer to the research conducted in Iraq over the prevalence of repeated abortions [25, 26] .
In the table (3) the high percentage and rate of positive Rubella IgG may be past infection or vaccine, such result agrees with another study which was done in Al-Diwaniyah Governorate-Iraq by Nama JK (2006 ), these studies showed that the greater of pregnant women with abortion are IgG seropositive and range of IgG positively 71%-84.2% in positive Rubella virus IgG in Al-Diwaniyah Governorate their significant difference p >0.05 [27] . In the same study showed the 8% positive Rubella IgM which showed the highest IgM seropositive in 3rd month of pregnant (10.7%) the study which was done in Iraq-Diyala province which is carried by Abul-Razak SH. Hasan, with colleagues (2010). The result in their study revealed that 3(5%) of pregnant women without previous abortion and revealed 8(26.7%) of pregnant with previous abortion were seropositive for anti-Rubella IgM [28] . in spite of the fact that the IFN-gamma release assay been over a wide area studied in adults and children, there were few data on test carried out throughout pregnancy. information indicating whether an other studies of non-pregnant adults shows that their tests are more specific for latent tuberculosis infections [10] . Al-Diwaniyah Province is an endemic area with tuberculosis and TB is actively investigated, allowing documentation of recent infection. Investigations on the Quantiferon test in different study group and control group according to age groups showed that out of recurrent miscarriage pregnant women have positive result 4 (5.33); Which details the results in the table (4) . Irreconcilable IFNGRA positive and Anti-rubella virus antibody (IgG, IgM) positive.The results were significantly less common occurred in pregnant women.The results in the table (5) comparison of results of Quantiferon assay and Antirubella virus antibody (IgG, IgM), overall agreement between the two screening methods were P-value 0.0443, with significant correlation.Studies on tuberculosis in pregnant women and their relationship to abortion have apparently not shown that TB causes abortion as a major cause, according to Zenner and his colleagues (2012) [9] .
CONCLUSION
The Rubella IgM (positive) in recurrent miscarriage showed that the number and percentage was (4) and (5.3%) respectively, no positive Rubella IgM was found in the control group, and rubella virus may be causes congenital abnormalities or sporadic abortion.Study of tuberculosis recurrent miscarriage was confused by
